LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-Time, At-Home Monitoring of Blood Pressure and Body Composition LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes LifeMD, a provider of virtual primary care services, and Withings Health Solutions, a leader in digital health technology, have formed a strategic partnership designed to revolutionize weight management patient care by providing LifeMDs GLP-1 weight-loss patients with Withings advanced in-home health monitoring devices, including the Body Pro 2 scale and the BPM Connect Pro blood pressure monitor
Dysregulated insulin signalling and neuronal insulin resistance occurs in SNCA mutant neurons To assess the integrity of dynamic neuronal insulin signalling, day-55 post-differentiation mDA neurons were selected and cultured for a further 7 days +/-25nM exenatide, and then incubated overnight without insulin
Comparison of the decrease in glycated hemoglobin levels of diabetic patients caused by a 40-week treatment with tirzepatide (5, 10 or 15 mg/wk) or semaglutide (1 mg/wk)
They look at eating habits, fluid intake when medicine is taken, and sleep routines
Many patients report feeling benefits within 1-3 days, while those with more severe deficiencies may need multiple injections to feel the effects
At the same time, GLP-1s are now understood to have potent anti-inflammatory effects in the brain that could reduce depression for individuals with depression related to inflammation
